SCHEMBL1403803

SCHEMBL1403803

OC1C(O)C(O)C(OP(O)(O)=S)C(O)C1O

nearest known ligand 0.67

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ INPP5A Q14642 2/20 0.67
▸ ITPR3 Q14573 7/20 0.48
▸ ITPR2 Q14571 3/20 0.48
▸ ITPR1 Q14643 3/20 0.48
▸ SMPD1 P17405 1/20 0.43
▸ INPPL1 O15357 1/20 0.40
▸ AKT1 P31749 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10345151 1.00 INPP5A (0.67) INPP5AITPR3ITPR2ITPR1SMPD1
SCHEMBL9414301 0.97 INPP5A (0.71) INPP5AITPR3ITPR2ITPR1SMPD1
SCHEMBL9414291 0.97 INPP5A (0.71) INPP5AITPR3ITPR2ITPR1SMPD1
SCHEMBL9414284 0.97 INPP5A (0.70) INPP5AITPR3ITPR2ITPR1SMPD1
SCHEMBL8460802 0.92 INPP5A (0.78) INPP5AITPR3ITPR2ITPR1SMPD1
SCHEMBL4456065 0.92 INPP5A (0.78) INPP5AITPR3ITPR2ITPR1SMPD1
SCHEMBL10345051 0.88 INPP5A (0.67) INPP5AITPR3ITPR2ITPR1SMPD1
SCHEMBL9414309 0.86 INPP5A (0.71) INPP5AITPR3ITPR2ITPR1SMPD1
SCHEMBL17124319 0.85 INPP5A (0.57) INPP5AITPR3ITPR2ITPR1SMPD1
SCHEMBL10344992 0.82 INPP5A (0.67) INPP5AITPR3ITPR2ITPR1SMPD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110212541-A1 COMPOSITIONS AND METHODS TO PROTECT CELLS BY BLOCKING ENTRY OF PATHOGEN PROTEINS VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) 2011-09-01 — — US claimed
WO-2011060144-A2 COMPOSITIONS AND METHODS TO PROTECT CELLS BY BLOCKING ENTRY OF PATHOGEN PROTEINS VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) 2011-05-19 — — WO claimed
EP-2291188-A2 COMPOSITIONS AND METHODS TO PROTECT CELLS BY BLOCKING ENTRY OF PATHOGEN PROTEINS Virginia Tech Intellectual Properties, Inc. (US) 2011-03-09 — — EP claimed
US-20100093601-A1 COMPOSITIONS AND METHODS TO PROTECT CELLS BY BLOCKING ENTRY OF PATHOGEN PROTEINS VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY 2010-04-15 — — US claimed
WO-2009143133-A2 COMPOSITIONS AND METHODS TO PROTECT CELLS BY BLOCKING ENTRY OF PATHOGEN PROTEINS VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) 2009-11-26 — — WO claimed
EP-0845475-B1 Inositolglycans with insular activity AVENTIS PHARMA GMBH (DE) 2005-03-09 — — EP claimed
US-6004938-A ANTIDIABETIC AGENTS; NON-INSULIN DEPENDENT DIABETES HOESCHT AKTIENGESELLSCHAFT (DE) 1999-12-21 — — US claimed
EP-0845475-A1 Inositolglycans with insular activity HOECHST AKTIENGESELLSCHAFT (DE) 1998-06-03 — — EP claimed
EP-0354904-A1 INOSITOL PHOSPHATE ANALOGUES 3i RESEARCH EXPLOITATION LIMITED (GB) 1990-02-21 — — EP claimed
WO-1988007047-A1 INOSITOL PHOSPHATE ANALOGUES RESEARCH CORPORATION LIMITED (GB) 1988-09-22 — — WO claimed
JP-10158291-A — — None — — JP disclosed
EP-0845475-B1 Inositolglycans with insular activity AVENTIS PHARMA GMBH (DE) 2005-03-09 — — EP disclosed
US-6004938-A ANTIDIABETIC AGENTS; NON-INSULIN DEPENDENT DIABETES HOESCHT AKTIENGESELLSCHAFT (DE) 1999-12-21 — — US disclosed
JP-H10158291-A INOSITOL GLUCAN HAVING INSULIN-LIKE ACTIVITY HOECHST AG 1998-06-16 — — JP disclosed
EP-0845475-A1 Inositolglycans with insular activity HOECHST AKTIENGESELLSCHAFT (DE) 1998-06-03 — — EP disclosed
EP-0845475-A1 Inositolglycans with insular activity HOECHST AKTIENGESELLSCHAFT (DE) 1998-06-03 — — EP disclosed
EP-0354904-A1 INOSITOL PHOSPHATE ANALOGUES 3i RESEARCH EXPLOITATION LIMITED (GB) 1990-02-21 — — EP disclosed
WO-1988007047-A1 INOSITOL PHOSPHATE ANALOGUES RESEARCH CORPORATION LIMITED (GB) 1988-09-22 — — WO disclosed
Send feedback